Achieve Life Sciences shares rise 2.26% premarket after FTC challenges Edwards Lifesciences Corp.'s acquisition of JenaValve Technology, Inc.

Achieve Life Sciences, Inc. rose 2.26% in premarket trading. The FTC's challenge to Edwards Lifesciences Corp.'s acquisition of JenaValve Technology, Inc. may have positively impacted Achieve Life Sciences, Inc. as it could reduce competition in the transcatheter aortic valve replacement (TAVR) devices market, potentially benefiting other companies in the sector.